ROCHE HLDG (RO.SW)


Swiss - Swiss Delayed Price. Currency in CHF
242.40-3.40 (-1.38%)
At close: 11:31 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open244.20
Prev Close245.80
Bid242.00 x 3700
Ask246.50 x 22300
Day's Range242.40 - 246.40
52wk Range233.70 - 280.00
1y Target EstN/A
Market CapN/A
P/E Ratio (ttm)N/A
BetaN/A
Volume27,515
Avg Vol (3m)20,132
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire22 days ago

    Roche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future

    The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.

  • PR Newswire22 days ago

    Roche launches new target enrichment systems for genetic and translational research

    OTCQX:RHHBY) today announced the global launch of the new HEAT-Seq¹ Target Enrichment Systems that provide rapid and accurate enrichment methods designed to improve the detection of variants in human genetics and cancer research. Molecular barcodes, or Unique Identifiers (UIDs), enable users to more accurately measure how much sequence data came from the sample itself, how much was unique and how much was redundant due to amplification during the PCR process. "The launch of our HEAT-Seq Target Enrichment Systems builds on Roche's commitment to driving the development of new tools for genomic medicine," said Neil Gunn, Head of Roche Sequencing Solutions.

  • PR Newswire23 days ago

    Roche receives CLIA waiver for cobas® Influenza A/B & RSV test for the cobas® Liat®

    PLEASANTON, Calif., Aug. 1, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance and CLIA (Clinical Laboratory ...